Assertion: hemolytic transfusion reaction | /r/HasProperty | dhtrs
Facets:
Source sentences:
text: Delayed hemolytic transfusion reactions (DHTRs) occur in patients who have received transfusions in the past.
text: Acute Hemolytic Transfusion Reaction (AHTR)
text: Delayed Hemolytic Transfusion Reaction (DHTR)
text: A hemolytic transfusion reaction (HTR) occurs when the immune system reacts to donated blood, resulting in the attack of your red blood cells.
text: Hemolytic transfusion reactions (HTRs):
text: Acute hemolytic transfusion reactions (AHTRs) occur in 1:76 000 RBC transfusions (Eder and Chambers, 2007).
text: In contrast to acute hemolytic transfusion reactions which are almost always due to ABO incompatibility, delayed hemolytic transfusion reactions (DHTRs) are typically secondary to antibodies associated with the Rh and Kidd systems (or other “minor” antigens).
text: Delayed hemolytic transfusion reactions (DHTRs) occur 3–10 days after the transfusion of RBC products that appear to be serologically compatible.
text: In delayed hemolytic transfusion reactions (DHTRs), accelerated hemolysis is indicated by increased serum bilirubin and lactate dehydrogenase concentrations and a decline in total hemoglobin compared with the early post-transfusion value.
text: In addition, alloimmunized patients are particularly prone to developing severe delayed hemolytic transfusion reactions (DHTRs), serious immune‐mediated complications that can occur following an RBC transfusion that can contribute to premature death.
text: Delayed hemolytic transfusion reactions (DHTRs) occur in patients who have received transfusions in the past.
text: In individuals with sickle cell disease, clinical manifestations of delayed hemolytic transfusion reactions (DHTRs) usually appear 5–15 days after the triggering transfusion, and include hemoglobinuria, jaundice, and pallor due to acute hemolysis.
text: In delayed hemolytic transfusion reactions (DHTRs), accelerated hemolysis is indicated by increased serum bilirubin and lactate dehydrogenase concentrations and a decline in total hemoglobin compared with the early post-transfusion value.
text: Red blood cell transfusions are often used to treat patients with sickle cell disease (SCD), and these patients are at risk for developing alloantibodies that can lead to delayed hemolytic transfusion reactions (DHTRs).
text: An acute hemolytic transfusion reaction (AHTR), also called immediate hemolytic transfusion reaction, is a life-threatening reaction to receiving a blood transfusion.
text: An acute hemolytic transfusion reaction (AHTR) is due to a blood type incompatibility (i.e. there are antibodies in recipient serum against donor red blood cell antigens) and is a class II (antigen-antibody) hypersensitivity reaction.
text: Acute hemolytic transfusion reaction (AHTR)
text: Delayed hemolytic transfusion reaction (DHTR)
text: The most common causes of IgG-mediated hemolysis are warm autoimmune hemolytic anemia (WAIHA) and delayed hemolytic transfusion reaction (DHTR).
text: A delayed hemolytic transfusion reaction (DHTR) is a type of transfusion reaction.
text: A hemolytic transfusion reaction (HTR) occurs when a patient gets blood products that are incompatible with his own blood.
text: In general, immediate hemolytic transfusion reactions (HTRs) from transfusion of incompatible PRBCs are because of the binding of naturally occurring IgM antibody to donor RBCs.
text: Acute hemolytic transfusion reactions (AHTRs) occur in 1:76 000 RBC transfusions (Eder and Chambers, 2007).